BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 18316469)

  • 1. Antioestrogen-mediated cell cycle arrest and apoptosis induction in breast cancer and multiple myeloma cells.
    Renoir JM; Bouclier C; Seguin A; Marsaud V; Sola B
    J Mol Endocrinol; 2008 Mar; 40(3):101-12. PubMed ID: 18316469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogenic or antiestrogenic therapies for multiple myeloma?
    Sola B; Renoir JM
    Mol Cancer; 2007 Sep; 6():59. PubMed ID: 17888187
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen receptor beta increases the efficacy of antiestrogens by effects on apoptosis and cell cycling in breast cancer cells.
    Hodges-Gallagher L; Valentine CD; El Bader S; Kushner PJ
    Breast Cancer Res Treat; 2008 May; 109(2):241-50. PubMed ID: 17638070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of breast cancer by chemical modulation of vulnerable zinc fingers in estrogen receptor.
    Wang LH; Yang XY; Zhang X; Mihalic K; Fan YX; Xiao W; Howard OM; Appella E; Maynard AT; Farrar WL
    Nat Med; 2004 Jan; 10(1):40-7. PubMed ID: 14702633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of NF-kappaB-mediated transcription and induction of apoptosis in human breast cancer cells by epoxypseudoisoeugenol-2-methyl butyrate.
    Ma G; Tabanca N; Husnu Can Baser K; Kirimer N; Pasco DS; Khan IA; Khan SI
    Cancer Chemother Pharmacol; 2009 Mar; 63(4):673-80. PubMed ID: 18597088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiproliferative effects of quercetin through cell cycle arrest and apoptosis in human breast cancer MDA-MB-453 cells.
    Choi EJ; Bae SM; Ahn WS
    Arch Pharm Res; 2008 Oct; 31(10):1281-5. PubMed ID: 18958418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The insulin-like growth factor-I receptor inhibitor NVP-AEW541 provokes cell cycle arrest and apoptosis in multiple myeloma cells.
    Maiso P; Ocio EM; Garayoa M; Montero JC; Hofmann F; García-Echeverría C; Zimmermann J; Pandiella A; San Miguel JF
    Br J Haematol; 2008 May; 141(4):470-82. PubMed ID: 18341634
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coenzyme Q0 induces apoptosis and modulates the cell cycle in estrogen receptor negative breast cancer cells.
    Somers-Edgar TJ; Rosengren RJ
    Anticancer Drugs; 2009 Jan; 20(1):33-40. PubMed ID: 18830129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-MeOE2bisMATE and 2-EtE2bisMATE induce cell cycle arrest and apoptosis in breast cancer xenografts as shown by a novel ex vivo technique.
    Foster PA; Ho YT; Newman SP; Kasprzyk PG; Leese MP; Potter BV; Reed MJ; Purohit A
    Breast Cancer Res Treat; 2008 Sep; 111(2):251-60. PubMed ID: 17957467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo anti-myeloma activity and modulation of gene expression profile induced by valproic acid, a histone deacetylase inhibitor.
    Neri P; Tagliaferri P; Di Martino MT; Calimeri T; Amodio N; Bulotta A; Ventura M; Eramo PO; Viscomi C; Arbitrio M; Rossi M; Caraglia M; Munshi NC; Anderson KC; Tassone P
    Br J Haematol; 2008 Nov; 143(4):520-31. PubMed ID: 18986388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of cell cycle arrest and apoptosis in myeloma cells by cepharanthine, a biscoclaurine alkaloid.
    Kikukawa Y; Okuno Y; Tatetsu H; Nakamura M; Harada N; Ueno S; Kamizaki Y; Mitsuya H; Hata H
    Int J Oncol; 2008 Oct; 33(4):807-14. PubMed ID: 18813795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HDAC inhibitor SNDX-275 induces apoptosis in erbB2-overexpressing breast cancer cells via down-regulation of erbB3 expression.
    Huang X; Gao L; Wang S; Lee CK; Ordentlich P; Liu B
    Cancer Res; 2009 Nov; 69(21):8403-11. PubMed ID: 19826038
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell cycle arrest and apoptosis responses of human breast epithelial cells to the synthetic organosulfur compound p-methoxyphenyl p-toluenesulfonate.
    Cyr L; Langler R; Lavigne C
    Anticancer Res; 2008; 28(5A):2753-63. PubMed ID: 19035306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitive effect of 3-bromopyruvic acid on human breast cancer MCF-7 cells involves cell cycle arrest and apoptotic induction.
    Liu XH; Zheng XF; Wang YL
    Chin Med J (Engl); 2009 Jul; 122(14):1681-5. PubMed ID: 19719971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer.
    Liu H; Zang C; Emde A; Planas-Silva MD; Rosche M; Kühnl A; Schulz CO; Elstner E; Possinger K; Eucker J
    Eur J Pharmacol; 2008 Sep; 591(1-3):43-51. PubMed ID: 18588872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A natural peptide, dolastatin 15, induces G2/M cell cycle arrest and apoptosis of human multiple myeloma cells.
    Sato M; Sagawa M; Nakazato T; Ikeda Y; Kizaki M
    Int J Oncol; 2007 Jun; 30(6):1453-9. PubMed ID: 17487366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biological evaluation of 2,3-dichloro-5,8-dimethoxy-1,4-naphthoquinone as an anti-breast cancer agent.
    Kanaan YM; Das JR; Bakare O; Enwerem NM; Berhe S; Beyene D; Williams V; Zhou Y; Copeland RL
    Anticancer Res; 2009 Jan; 29(1):191-9. PubMed ID: 19331150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PEGylated conjugated linoleic acid stimulation of apoptosis via a p53-mediated signaling pathway in MCF-7 breast cancer cells.
    Seo JH; Moon HS; Kim IY; Guo DD; Lee HG; Choi YJ; Cho CS
    Eur J Pharm Biopharm; 2008 Oct; 70(2):621-6. PubMed ID: 18573337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ectopic cyclin D1 overexpression increases chemosensitivity but not cell proliferation in multiple myeloma.
    Kuroda Y; Sakai A; Tsuyama N; Katayama Y; Munemasa S; Asaoku H; Okikawa Y; Nakaju N; Mizuno M; Ogawa K; Nishisaka T; Matsui H; Tanaka H; Kimura A
    Int J Oncol; 2008 Dec; 33(6):1201-13. PubMed ID: 19020753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The rational designed antagonist derived from the complex structure of interleukin-6 and its receptor affectively blocking interleukin-6 might be a promising treatment in multiple myeloma.
    Feng J; Yang Z; Li Y; Hu M; Yu M; Qin W; Sun J; Shen B
    Biochimie; 2006 Sep; 88(9):1265-73. PubMed ID: 16626851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.